WebFeb 22, 2024 · NEW YORK, Feb. 22, 2024 /PRNewswire/ -- Meliora Health, a telehealth-based behavioral health company focused on mental health, autism, and attention deficit hyperactivity disorder (ADHD) conditions... WebHealios AG is a MedTech company aiming to develop and validate digital biomarkers Basel, Basel-Stadt, Switzerland 11-50 Seed Private www.healios.io 36,875 Highlights Total Funding Amount $4.2M Employee Profiles 3 Investors 2 Similar Companies 12 Details Industries Clinical Trials Medical Device Founded Date 2014
Jessica B. - Senior Designer - Healios LinkedIn
WebApr 7, 2024 · HEALIOS K.K. is a Japan-based company mainly engaged in research and development of pharmaceutical products. The Company has compound pharmaceutical products line and induced pluripotent stem cell (iPSC) regenerative medicine product line. The compound pharmaceutical product line contains HLM0021, HLM0022 and HLM0023. WebHome - Healios Proud partners of Your mental health, autism and ADHD service Helping children and young people to thrive by reimagining access to life-changing care At … Healios has been a digital service provider since the start. And we remain at the … Developed by experts with the help of children and young people, ThinkNinja … Want to learn more about how Healios supports children and teens with their … Healios Academy is a unique training programme that gives healthcare … Alternatively, email [email protected] or call 0330 124 4222 between 8am and … Whether you are a child or young person, healthcare professional or teacher, you … Want to learn more about how Healios supports children and teens with their … From assessment and diagnosis through to ongoing support, our services are … As part of the Healios family, Melios shares our mission to help all children and … fairyland utah
Athersys Reports That Its Partner, HEALIOS K.K., Provides Updates …
WebMar 31, 2024 · Healios is a pioneer in the development of regenerative medicines in Japan, where it has established a proprietary, gene-edited “universal donor” induced pluripotent stem cell (iPSC) line to develop next generation regenerative treatments in immuno-oncology, ophthalmology, liver diseases, and other areas of severe unmet medical need. WebHEALIOS K.K. ("Healios") is currently conducting two clinical trials using stem cell product HLCM051*1 for ischemic stroke and acute respiratory distress syndrome (ARDS)*2 (the "ONE-BRIDGE" study) patients in Japan. ONE-BRIDGE is a Phase II efficacy and safety trial for patients with pneumonia induced ARDS. WebAug 5, 2024 · Healios is a pioneer in the development of regenerative medicines in Japan, where it leverages its proprietary, gene-edited “universal donor” induced pluripotent stem cell (iPSC) platform... fairyland yellowstone